RPL21P127

Across TCGA pan-cancer cohorts, RPL21P127 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RPL21P127 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RPL21P127 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL21P127 expression acts as an unfavorable survival marker, although some lineages such as SKCM and BLCA show a favorable association.

OV, UCEC, and KICH are the cancer types where RPL21P127 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Median	II,III,IV	0.484	0.592	.001	58	view →
UCEC	DFS	Tertile	All	0.824	0.914	.002	48	view →
KICH	DFS	Quartile	All	0.582	0.900	.003	46	view →
MESO	OS	Tertile	III,IV	0.314	0.633	<.001	33	view →
ACC	OS	Tertile	All	0.618	0.917	.015	30	view →
UVM	OS	Tertile	All	0.629	0.928	.007	27	view →
SKCM	OS	Median	II,III,IV	0.932	0.777	.001	26	view →
BRCA	DFS	Quartile	II,III,IV	0.832	0.904	.007	20	view →
READ	DFS	Tertile	IV	0.375	0.718	.009	15	view →
BLCA	DFS	Tertile	IV	0.604	0.263	.014	13	view →
THYM	OS	Quartile	III,IV	0.610	1.000	.013	12	view →
THCA	DFS	Tertile	IV	0.436	0.824	.005	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RPL21P127–OV (DFS)

Open the OV breakdown →